JPRN-UMIN000006519已完成未知
Effect of risedronate combined with vitamin K2 in patients with osteoporosis due to the steroid therapy - Efficancy of concurrent use of vitamin K2 with risedronate
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine0 个研究点目标入组 100 人开始时间: 2011年10月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Contraindication for risedronate use 2. medicated with Warfarin 3. Using other osteoporosis drugs (active vitamin D3,SERM, ipriflavone, calcitonin, bisphosphonate) 4. Patients judged inappropriate by attending physisians
研究者
相似试验
已完成
不适用
Preventive effect of vit K, vit D and, risedronate on 3-dimensional trabecular microstructure in patients with IgA nephropathy on glucocorticoid treatmentGlucocorticoid induced osteoporosis in patients with IgA nephropathyJPRN-UMIN000002474Osaka University Hospital Department of nephrology30
已完成
不适用
The effectiveness of a Vitamin K2 analog on the recurrence of HCC after curative therapypatients with HCC after curative treatmentJPRN-C000000431ational Hospital Organization Iwakuni Clinical Center60
招募中
2 期
The effects of Vitamin K2 supplementation on the progression of Coronary Artery Calcificatiocoronary atherosclerosiscoronary calcification1001108210057166NL-OMON46941Interne Geneeskunde180
已完成
3 期
The effects of alendronate and Vitamin K on postmenopausal osteoporosispostmenopausal osteoporosisOsteoporosis.IRCT201504141479N3Vice president for research, Mashhad University of Medical Sciences50
已完成
不适用
Prevention of incident fracture of Osteoporosis in Japan(Multi-center Randomized Trial with Risedronate and VitaminK2)OsteoporosisJPRN-UMIN000000991Japan Osteoporosis Society/A-TOP consortium1,983